Concepedia

Rafee Talukder

RT

6

Publications

253

Citations

6

H-Index

2021

Active since

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

Cleveland Clinic

University of California, San Francisco

Stanford University

Rafee Talukder is an author at University of Washington specializing in cancer therapeutics, urology, and medicine.

ORCID

Top concepts

Publications per year

2021–2024

6

Publications

6

Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

Faisal Fa’ak, Maryam Buni, Adewunmi Falohun et al. · Journal for ImmunoTherapy of Cancer · 2023 · 84 citations · Full text

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 80 citations · Full text

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2023 · 26 citations · Full text

, , +8

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2022 · 25 citations · Full text

, , +8

Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Dimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder et al. · Clinical Genitourinary Cancer · 2022 · 22 citations · Full text

Rows per page

1–5 of 6